EirGen Pharma Overview
- Year Founded
-
2005
- Status
-
Acquired/Merged
- Employees
-
200
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$134M
- Investors
-
1
EirGen Pharma General Information
Description
Manufacturer of high-potency oral doses and soft-gel-based pharmaceutical products intended for clinical and commercial use. The company provides development, manufacturing, and packaging services for solid and semi-solid forms using controlled facilities, high-containment systems, and regulated processes that support oncology, hormonal, and veterinary applications, enabling healthcare organizations and related sectors to access accurately produced materials and maintain compliance across different regions.
Contact Information
Website
www.eirgen.com(Operating Subsidiary)
Corporate Office
- Westside Business Park
- Old Kilmeaden Road
- Waterford X91 YV67
- Ireland
Corporate Office
- Westside Business Park
- Old Kilmeaden Road
- Waterford X91 YV67
- Ireland
EirGen Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 05-May-2015 | $134M | Completed | Generating Revenue | ||
| 2. Corporate | 24-Mar-2012 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
EirGen Pharma Comparisons
Industry
Financing
Details
EirGen Pharma Competitors (20)
One of EirGen Pharma’s 20 competitors is Glenmark Pharmaceuticals, a Corporation company based in Mumbai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Glenmark Pharmaceuticals | Corporation | Mumbai, India | ||||
| Aytu Biopharma | Corporation | Denver, CO | ||||
| Zydus Lifesciences | Corporation | Ahmedabad, India | ||||
| Evonile Pharma | Private Equity-Backed | Mumbai, India | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria |
EirGen Pharma Patents
EirGen Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026231342-A1 | A combination of scyllo-inositol and caronsic acid | Pending | 01-May-2025 | ||
| WO-2025254861-A1 | A combination of scyllo-inositol and n-acetyl cysteine and related compounds | Pending | 04-Jun-2024 | ||
| EP-4801512-A1 | Controlling loss of kidney function | Pending | 02-Nov-2023 | ||
| WO-2025094144-A1 | Controlling loss of kidney function | Inactive | 02-Nov-2023 | ||
| US-20260355128-A1 | Scyllo-inositol in combination with immunotherapeutics for the treatment of alzheimer's disease | Pending | 27-Jan-2023 | A61K31/047 |
EirGen Pharma Signals
EirGen Pharma Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| SPIMACO | Corporation | Minority |
EirGen Pharma FAQs
-
When was EirGen Pharma founded?
EirGen Pharma was founded in 2005.
-
Where is EirGen Pharma headquartered?
EirGen Pharma is headquartered in Waterford, Ireland.
-
What is the size of EirGen Pharma?
EirGen Pharma has 200 total employees.
-
What industry is EirGen Pharma in?
EirGen Pharma’s primary industry is Pharmaceuticals.
-
Is EirGen Pharma a private or public company?
EirGen Pharma is a Private company.
-
What is the current valuation of EirGen Pharma?
The current valuation of EirGen Pharma is .
-
What is EirGen Pharma’s current revenue?
The current revenue for EirGen Pharma is .
-
Who are EirGen Pharma’s investors?
SPIMACO has invested in EirGen Pharma.
-
Who are EirGen Pharma’s competitors?
Glenmark Pharmaceuticals, Aytu Biopharma, Zydus Lifesciences, Evonile Pharma, and Pfizer (Vienna) are some of the 20 competitors of EirGen Pharma.
-
When was EirGen Pharma acquired?
EirGen Pharma was acquired on 05-May-2015.
-
Who acquired EirGen Pharma?
EirGen Pharma was acquired by OPKO Health.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process